TransMedics Group Inc (TMDX)
89.25
+0.37
(+0.42%)
USD |
NASDAQ |
Apr 25, 16:00
89.22
-0.03
(-0.03%)
After-Hours: 20:00
TransMedics Group Cash from Investing (TTM): -193.95M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -193.95M |
September 30, 2023 | -154.90M |
June 30, 2023 | 19.68M |
March 31, 2023 | 43.07M |
December 31, 2022 | 54.51M |
September 30, 2022 | 67.27M |
June 30, 2022 | 48.72M |
March 31, 2022 | 30.51M |
December 31, 2021 | 29.27M |
September 30, 2021 | 29.16M |
June 30, 2021 | -0.513M |
Date | Value |
---|---|
March 31, 2021 | -45.04M |
December 31, 2020 | -41.60M |
September 30, 2020 | -44.12M |
June 30, 2020 | -39.41M |
March 31, 2020 | -47.78M |
December 31, 2019 | -60.50M |
September 30, 2019 | -68.00M |
June 30, 2019 | -48.72M |
March 31, 2019 | 7.344M |
December 31, 2018 | 12.31M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-193.95M
Minimum
Dec 2023
67.27M
Maximum
Sep 2022
-22.23M
Average
-39.41M
Median
Jun 2020
Cash from Investing (TTM) Benchmarks
SI-BONE Inc | -59.80M |
Cutera Inc | 165.00M |
Stereotaxis Inc | 19.76M |
Electromed Inc | -1.219M |
Myomo Inc | -2.030M |